MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
John P. Cheatham, MD, Delivers SCAI Mullins Lecture on Hybrid Procedures
May 5, 2011—John P. Cheatham, MD, delivered the keynote Mullins Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 scientific sessions in Baltimore, Maryland. Dr. Cheatham described how hybrid procedures combining the disciplines of interventional cardiology and cardiac surgery are resulting in stronger and more adaptable approaches in the treatment of birth defects of the heart.
Transcatheter Closure of ASDs
An overview of therapeutic options for atrial septal defect closure.
By Ralf J. Holzer, MD, Msc, and John P. Cheatham, MD, FAAP, FACC, Fscai
Seven-Year Outcomes Published From IDE Trial of Medtronic's Melody TPV
May 14, 2015—John P. Cheatham, MD, et al published results from the United States Melody transcatheter pulmonary valve (TPV; Medtronic, plc) investigational device exemption (IDE) trial, including clinical and hemodynamic outcomes up to 7 years after the TPV replacement (TPVR) procedure. The findings are available online ahead of print in Circulation.
Managing Complications
By Ted E. Feldman, MD, Chief Medical Editor
Medtronic Presents Data on Melody and Harmony TPV Devices for Congenital Heart Disease
May 15, 2020—Medtronic announced the results from two late-breaking clinical trials presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2020 Scientific Sessions Virtual Conference held May 14–16.
Stenting Coarctation of the Aorta
Indications, techniques, and outcomes in treating native and recurrent CoA.
By Thomas J. Forbes, MD, FACC, FSCAI, and Daisuke Kobayashi, MD
